KRISTIN WYMER: Open Payments
NPI 1679058762 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $463 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 6 | $221 |
| Novartis Pharmaceuticals Corporation | 10 | $172 |
| Incyte Corporation | 2 | $59 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| ABBVIE INC. | 2 | $32 |
| Lilly USA, LLC | 1 | $22 |
| Organon LLC | 1 | $22 |
| GENZYME CORPORATION | 1 | $16 |
Products named: NEMLUVIO, COSENTYX, OPZELURA, TREMFYA, DUPIXENT, Leqselvi, TALTZ, HADLIMA.
Industry payments across IN — which companies pay providers there.
